Your search returned 11 results.

Results
	1.	DNA minor groove targeted alkylating agents based on bisbenzimidazole carriers: synthesis, cytotoxicity and sequence-specificity of DNA alkylation. [electronic resource] by Smaill, J B Fan, J Y Denny, W A Producer: 19990607 In: Anti-cancer drug design vol. 13 Availability: No items available. Save to lists Add to cart (remove)
	2.	Mono- and dysfunctional nitrogen mustard analogues of the DNA minor groove binder pibenzimol. Synthesis, cytotoxicity and interaction with DNA. [electronic resource] by Smaill, J B Fan, J Y Papa, P V O'Connor, C J Denny, W A Producer: 19980605 In: Anti-cancer drug design vol. 13 Availability: No items available. Save to lists Add to cart (remove)
	3.	Toward a high-throughput screening platform for directed evolution of enzymes that activate genotoxic prodrugs. [electronic resource] by Copp, J N Williams, E M Rich, M H Patterson, A V Smaill, J B Ackerley, D F Producer: 20150611 In: Protein engineering, design & selection : PEDS vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Targeted mutagenesis of the Vibrio fischeri flavin reductase FRase I to improve activation of the anticancer prodrug CB1954. [electronic resource] by Swe, P M Copp, J N Green, L K Guise, C P Mowday, A M Smaill, J B Patterson, A V Ackerley, D F Producer: 20121019 In: Biochemical pharmacology vol. 84 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Discovery and evaluation of Escherichia coli nitroreductases that activate the anti-cancer prodrug CB1954. [electronic resource] by Prosser, G A Copp, J N Syddall, S P Williams, E M Smaill, J B Wilson, W R Patterson, A V Ackerley, D F Producer: 20100223 In: Biochemical pharmacology vol. 79 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	The nitroreductase prodrug SN 28343 enhances the potency of systemically administered armed oncolytic adenovirus ONYX-411(NTR). [electronic resource] by Singleton, D C Li, D Bai, S Y Syddall, S P Smaill, J B Shen, Y Denny, W A Wilson, W R Patterson, A V Producer: 20080228 In: Cancer gene therapy vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Tyrosine kinase inhibitors. 17. Irreversible inhibitors of the epidermal growth factor receptor: 4-(phenylamino)quinazoline- and 4-(phenylamino)pyrido[3,2-d]pyrimidine-6-acrylamides bearing additional solubilizing functions. [electronic resource] by Smaill, J B Rewcastle, G W Loo, J A Greis, K D Chan, O H Reyner, E L Lipka, E Showalter, H D Vincent, P W Elliott, W L Denny, W A Producer: 20020802 In: Journal of medicinal chemistry vol. 43 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Tyrosine kinase inhibitors. 18. 6-Substituted 4-anilinoquinazolines and 4-anilinopyrido[3,4-d]pyrimidines as soluble, irreversible inhibitors of the epidermal growth factor receptor. [electronic resource] by Smaill, J B Showalter, H D Zhou, H Bridges, A J McNamara, D J Fry, D W Nelson, J M Sherwood, V Vincent, P W Roberts, B J Elliott, W L Denny, W A Producer: 20010802 In: Journal of medicinal chemistry vol. 44 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Structure-activity relationships for 1-phenylbenzimidazoles as selective ATP site inhibitors of the platelet-derived growth factor receptor. [electronic resource] by Palmer, B D Smaill, J B Boyd, M Boschelli, D H Doherty, A M Hamby, J M Khatana, S S Kramer, J B Kraker, A J Panek, R L Lu, G H Dahring, T K Winters, R T Showalter, H D Denny, W A Producer: 19990201 In: Journal of medicinal chemistry vol. 41 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor. [electronic resource] by Fry, D W Bridges, A J Denny, W A Doherty, A Greis, K D Hicks, J L Hook, K E Keller, P R Leopold, W R Loo, J A McNamara, D J Nelson, J M Sherwood, V Smaill, J B Trumpp-Kallmeyer, S Dobrusin, E M Producer: 19981022 In: Proceedings of the National Academy of Sciences of the United States of America vol. 95 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Tyrosine kinase inhibitors. 15. 4-(Phenylamino)quinazoline and 4-(phenylamino)pyrido[d]pyrimidine acrylamides as irreversible inhibitors of the ATP binding site of the epidermal growth factor receptor. [electronic resource] by Smaill, J B Palmer, B D Rewcastle, G W Denny, W A McNamara, D J Dobrusin, E M Bridges, A J Zhou, H Showalter, H D Winters, R T Leopold, W R Fry, D W Nelson, J M Slintak, V Elliot, W L Roberts, B J Vincent, P W Patmore, S J Producer: 19990610 In: Journal of medicinal chemistry vol. 42 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)